We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SRZN market cap is 20.38M. The company's latest EPS is USD -21.1162 and P/E is -0.47.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 12.5M | 0 | 0 | 0 |
| Operating Income | -13.61M | -2.17M | -14.59M | -10.28M | -11.19M |
| Net Income | -13.36M | -775k | -14.3M | -9.39M | -10.45M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 12.5M | 0 |
| Operating Income | -546k | -54.39M | -44.34M | -45.78M |
| Net Income | -2.12M | -54.65M | -36M | -43.04M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 91.43M | 89.44M | 74.2M | 64M | 53.97M |
| Total Liabilities | 13.94M | 13.43M | 11.16M | 8.94M | 8.44M |
| Total Equity | 77.49M | 76M | 63.04M | 55.06M | 45.53M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 93.78M | 137.17M | 89.44M | 46.08M |
| Total Liabilities | 6.91M | 27.47M | 13.43M | 8.15M |
| Total Equity | 5M | 109.7M | 76M | 37.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -43.94M | -44.15M | -14.17M | -22.92M | -33.05M |
| Investing | 36.4M | 38.31M | 17.33M | 34.58M | 42.22M |
| Financing | -16k | -2.57M | -39k | 148k | 135k |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -934k | -48.81M | -44.15M | -40.36M |
| Investing | -92M | -77.71M | 38.31M | 51.72M |
| Financing | 93.92M | 124.63M | -2.57M | 276k |
| Market Cap | 20.38M |
| Price to Earnings Ratio | -0.47 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.57 |
| Price to Book Ratio | 0.54 |
| Dividend Yield | - |
| Shares Outstanding | 2.04M |
| Average Volume (1 week) | 8.66k |
| Average Volume (1 Month) | 12.59k |
| 52 Week Change | 9.29% |
| 52 Week High | 16.19 |
| 52 Week Low | 4.50 |
| Spread (Intraday) | 5.81 (37.83%) |
| Company Name | Surrozen Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.surrozen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
